Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix

NCT04779918 is registered in ClinicalTrials.gov with Tela Bio Inc as lead sponsor.

NCT NCT04779918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04779918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix
Lead sponsor
Tela Bio Inc
Phase
Not applicable
Overall status
Recruiting
Start date
April 29, 2021
Completion date
December 30, 2029
Enrollment
160 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hernia, inguinal, hernia, ventral